We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
+11.71%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$457M
AUM Growth
+$138M
(+43%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
27.38%
Top 10 Holdings %
Top 10 Hldgs %
5.56%
Holding
1,008
New
380
Increased
191
Reduced
147
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
+$3.1M |
| 2 |
TTCF
Tattooed Chef, Inc Class A Common Stock
TTCF
|
+$2.96M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$2.77M |
| 4 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$2.76M |
| 5 |
Albemarle
ALB
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingersoll Rand
IR
|
+$1.79M |
| 2 |
International Flavors & Fragrances
IFF
|
+$1.78M |
| 3 |
Baxter International
BAX
|
+$1.75M |
| 4 |
VMW
VMware, Inc
VMW
|
+$1.71M |
| 5 |
RB Global
RBA
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.25% |
| 2 | Industrials | 17.15% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Clearway Energy Class C
CWEN
$4.94B
| $211K | 0.05% |
7,486
-6,919
| -48% | -$212K |
|
602
Modine Manufacturing
MOD
$10.4B
| $211K | 0.05% |
14,267
+273
| +2% | +$3.88K |
|
|
SC
603
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $211K | 0.05% |
+7,792
| New | +$195K |
|
604
DexCom
DXCM
$32.6B
| $210K | 0.05% |
+2,340
| New | +$220K |
|
605
Arista Networks
ANET
$238B
| $209K | 0.05% |
+11,072
| New | +$207K |
|
606
Paycom
PAYC
$7.97B
| $209K | 0.05% |
+566
| New | +$223K |
|
607
Williams-Sonoma
WSM
$29B
| $209K | 0.05% |
2,332
-2,680
| -53% | -$181K |
|
608
LCI Industries
LCII
$2.51B
| $208K | 0.05% |
1,571
-1,588
| -50% | -$222K |
|
609
Teledyne Technologies
TDY
$31.4B
| $208K | 0.05% |
+503
| New | +$194K |
|
610
ABM Industries
ABM
$2.86B
| $206K | 0.05% |
+4,033
| New | +$177K |
|
611
Iridium Communications
IRDM
$5.17B
| $206K | 0.05% |
+5,000
| New | +$219K |
|
612
NextCure
NXTC
$21.7M
| $205K | 0.04% |
1,708
-905
| -35% | -$131K |
|
613
Kforce
KFRC
$1.02B
| $204K | 0.04% |
+3,812
| New | +$184K |
|
614
Lowe's Companies
LOW
$119B
| $204K | 0.04% |
1,073
-4,548
| -81% | -$780K |
|
615
Evolent Health
EVH
$341M
| $203K | 0.04% |
10,025
-5,115
| -34% | -$97.3K |
|
|
CONN
616
DELISTED
Conn's Inc.
CONN
| $203K | 0.04% |
+10,434
| New | +$154K |
|
617
Arcutis Biotherapeutics
ARQT
$3.23B
| $202K | 0.04% |
6,979
-5,542
| -44% | -$173K |
|
|
SCU
618
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $202K | 0.04% |
+9,249
| New | +$183K |
|
|
ONEM
619
DELISTED
1Life Healthcare
ONEM
| $202K | 0.04% |
5,168
-9,248
| -64% | -$434K |
|
|
ESTE
620
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $202K | 0.04% |
28,276
+18,252
| +182% | +$124K |
|
621
CNA Financial
CNA
$14.3B
| $201K | 0.04% |
+4,500
| New | +$192K |
|
|
JAMF
622
DELISTED
Jamf
JAMF
| $201K | 0.04% |
5,677
-9,087
| -62% | -$332K |
|
623
Relmada Therapeutics
RLMD
$568M
| $201K | 0.04% |
5,708
-1,007
| -15% | -$35.2K |
|
|
PRTK
624
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $201K | 0.04% |
28,530
+1,678
| +6% | +$12.1K |
|
625
Phillips 66
PSX
$81.5B
| $200K | 0.04% |
2,458
-2,092
| -46% | -$164K |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
OFS
LOAME
DP
Occudo Quantitative Strategies's Q1 2021 Portfolio in Review
As of Q1 2021, Occudo Quantitative Strategies held 1,008 positions worth $457M, up 43% from $319M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
Occudo Quantitative Strategies deployed $125M of net new capital in Q1 2021, opening 380 new positions and adding to 191 existing holdings. Its largest new stake was Athenex, Inc. Common Stock: 16,167 shares worth $1.39M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Ingersoll Rand, an estimated $1.79M trimmed.
- Occudo Quantitative Strategies's largest Q1 2021 buy was Athenex, Inc. Common Stock: 16,167 shares worth $1.39M.
- Occudo Quantitative Strategies added most to Odonate Therapeutics, Inc. Common Stock in Q1 2021, an estimated $2.67M increase.
- Occudo Quantitative Strategies's biggest Q1 2021 reduction was Ingersoll Rand, cutting an estimated $1.79M.
- Occudo Quantitative Strategies fully exited International Flavors & Fragrances in Q1 2021, selling an estimated $1.78M.
- Occudo Quantitative Strategies's ten largest holdings make up 5.6% of its $457M portfolio in Q1 2021.
- Occudo Quantitative Strategies opened 380 new positions and closed 287 in Q1 2021.
- Occudo Quantitative Strategies's portfolio value rose 43% quarter-over-quarter to $457M.
Based on Occudo Quantitative Strategies's 13F filing for Q1 2021, filed 14 May 2021.